Korea's National Growth Fund Approves Seven Initial Projects
Summary
Korea's Financial Services Commission announced approvals for seven projects totaling approximately KRW 1.6 trillion, providing an early view of how the National Growth Fund is being applied across strategic-industry equity, project financing and loans.
- The announced package covers seven projects and approximately KRW 1.6 trillion; it should be read as approved financing, not as evidence that the full amount has already been deployed.
- The instruments vary by project, including direct preferred-equity investment, investment through project-specific vehicles and loans, so the headline total does not represent a single risk or return profile.
- For overseas investors, the first approvals identify areas where Korean policy capital is seeking to complement private capital, but each transaction still requires project-level diligence.
The first approvals show how the fund is beginning to operate across different financing instruments. The headline total alone does not describe the terms or implementation status of each project.
Analysis
At a meeting held on 27 August 2026, the National Growth Fund's investment committee approved seven projects with an aggregate financing scale of approximately KRW 1.6 trillion, according to Korea's Financial Services Commission. The Ministry of Trade, Industry and Energy also published supporting material on the approvals.
The largest disclosed project was a KRW 560 billion low-interest loan for Doosan Tesna's semiconductor testing capacity. Other approvals included a KRW 300 billion loan for LG Energy Solution's battery manufacturing investment and a KRW 350 billion financing package for Wonik Robotics.
The Wonik Robotics package comprises KRW 150 billion of direct investment through convertible preferred shares from the Advanced Strategic Industry Fund and KRW 200 billion of equity to be raised from private investors. CJ 4DPLEX received approval for a KRW 220 billion equity investment for the expansion of its technology-enabled cinema venues.
The remaining approvals were loans for TKG Solmics, Kyongbo Pharmaceutical and Samdong totaling approximately KRW 170 billion. The projects span semiconductors, batteries, robotics, cultural content, pharmaceuticals and advanced materials.
The FSC also reported KRW 17.9 trillion of cumulative approvals or fund formation through August across direct investment, indirect investment, infrastructure and low-interest lending. That figure combines different stages and instruments and should not be interpreted as cash already invested in operating assets.
The initial portfolio indicates that implementation is moving from fund design to transaction selection. For institutional investors, the relevant next questions are the precise capital structure, policy-capital seniority, governance rights, private-capital participation and whether subsequent approvals establish repeatable co-investment channels.
Why it matters
The first approvals make the fund's implementation model more concrete and show where public financing may affect project economics or financing availability. The documents also demonstrate why approval, fund formation and deployed capital need to be considered separately.
Questions for further review
- Separate approved financing from cash actually deployed at each project.
- Confirm instrument terms, ranking, governance rights, and private-capital participation before assessing any co-investment relevance.
- Track whether later approvals establish a repeatable channel or remain project-specific.